Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Market Cap | $291 | $693 | $683 |
| - Cash | $3 | $0 | $1 |
| + Debt | $2 | $1 | $0 |
| Enterprise Value | $289 | $693 | $682 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$16 | -$6 | -$0 |
| % Margin | – | – | – |
| Net Income | -$11 | -$1 | -$0 |
| % Margin | – | – | – |
| EPS Diluted | -0.22 | -0.01 | -0.005 |
| % Growth | -2,122.2% | -115.2% | – |
| Operating Cash Flow | -$6 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$1 | -$1 |